Cti Biopharm Corp (CTIC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2013 | 12-2012 | 09-2012 | 06-2012 | 03-2012 | |
| Sales | 1,126 | 0 | 0 | 0 | 0 |
| Cost of Goods | 55 | N/A | 0 | 0 | 0 |
| Gross Profit | 1,071 | N/A | N/A | N/A | N/A |
| Operating Expenses | 19,648 | 18,850 | 15,149 | 49,400 | 18,098 |
| Operating Income | -18,522 | -18,850 | -15,149 | -49,400 | -18,098 |
| Interest Expense | 48 | 5 | 43 | 3 | 5 |
| Other Income | -1,046 | 141 | -54 | -795 | 574 |
| Pre-tax Income | -19,616 | -18,714 | -15,246 | -50,198 | -17,529 |
| Net Income Continuous | -19,616 | -18,714 | -15,246 | -50,198 | -17,529 |
| Minority Interests | -232 | -113 | -57 | -60 | -83 |
| Net Income | $-19,384 | $-18,601 | $-15,189 | $-50,138 | $-17,446 |
| EPS Basic Total Ops | -1.80 | 2.10 | -3.80 | -13.80 | -4.30 |
| EPS Basic Continuous Ops | -1.84 | 1.49 | -2.88 | -11.80 | -4.30 |
| EPS Diluted Total Ops | -1.80 | 2.10 | -3.80 | -13.80 | -4.30 |
| EPS Diluted Continuous Ops | -1.84 | 1.49 | -2.88 | -11.80 | -4.30 |
| EBITDA(a) | $-18,111 | $-18,249 | $-14,490 | $-48,835 | $-17,577 |